[Clinical experience with a new antispasmodic-analgesic combination (preliminary note)].
D000328:Adult; D000588:Amines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D003085:Colic / Q000188:drug therapy; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy; D008744:Methylamines / Q000627:therapeutic use; D009120:Muscle Cramp / Q000188:drug therapy; D010276:Parasympatholytics / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D013451:Sulfonic Acids / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines; D010276:Parasympatholytics; D011720:Pyrazoles; D011725:Pyridines; D013451:Sulfonic Acids
Experiência clínica com nova associaçào analgésica antispasmódica (nota prévia.